Zobrazeno 1 - 10
of 118
pro vyhledávání: '"Pekka, Lähteenmäki"'
Autor:
Gita Ramjee, Sumentheran N. Govender, Barbara Friedland, Michelle M. Chau, Constance Monedi, Khatija Ahmed, Stephanie Skoler-Karpoff, Neetha S. Morar, Pekka Lähteenmäki, Marie Stoner, Robin A. Maguire, Lydia Altini, Marlena Gehret Plagianos
Publikováno v:
AIDS and Behavior
A randomized, placebo-controlled, efficacy trial of Carraguard was unable to demonstrate a reduction in women's risk of HIV infection, which may have been due, in part, to low adherence (gel used in 42 % of vaginal sex acts, on average). A secondary
Publikováno v:
Human Reproduction. 30:1580-1588
STUDY QUESTION: Is small uterine cavity size as assessed by ultrasonography associated with bleeding problems or pain in nulligravid women using intrauterine contraception or do other factors affect these parameters? SUMMARY ANSWER: Among levonorgest
Publikováno v:
Obstetrics & Gynecology. 124:345-353
OBJECTIVE: To assess the relationship of preinsertion vaginal ultrasound assessment and menstrual and gynecologic history as predictors of difficult or painful intrauterine device insertion in nulligravid women. METHODS: Nulligravid women seeking con
Publikováno v:
Human Reproduction. 28(6):1546-1551
Study questions What are the symptoms of uterine perforation caused by modern copper intrauterine devices (Cu-IUDs) and the levonorgestrel-releasing intrauterine system (LNG-IUS); how is perforation detected and what are the findings in abdominal sur
Autor:
Barbara Friedland, Pekka Lähteenmäki, Janneke van de Wijgert, Gita Ramjee, Stephanie Skoler-Karpoff, Cynthia Kwok, Marlena Gehret-Plagianos, Pai-Lien Chen, Khatija Ahmed, Charles S. Morrison, Smruti Patel
Publikováno v:
AIDS (London, England), 26(4), 497-504. Lippincott Williams and Wilkins
Objectives: To evaluate the effect of hormonal contraception including combined oral contraceptives (COCs), and the injectable progestins depo-medroxyprogesterone acetate (DMPA) and norethisterone enanthate (Net-En) on the risk of HIV acquisition amo
Autor:
Oskari Heikinheimo, Pekka Lähteenmäki
Publikováno v:
Human Reproduction Update
BACKGROUND More than 15 million women, many of reproductive age, were infected with human immunodeficiency virus (HIV) at the end of 2007. As the HIV epidemic evolves, heterosexual intercourse is increasingly risky: the risk of infection in exposed y
Publikováno v:
Contraception. 68:421-426
The pharmacokinetics of mifepristone is characterized by rapid absorption, a long half-life of 25-30 h, and high micromolar serum concentrations following ingestion of doses of >/=100 mg of the drug. The serum transport protein-alpha 1-acid glycoprot
Publikováno v:
Acta Obstetricia et Gynecologica Scandinavica. 82:167-172
Objective. To evaluate the efficacy of three different doses of Nestorone ® progestin administered by implants for relief of pain, as well as bleeding patterns and symptoms in women with endometriosis. Design. An open clinical study without a contro
Publikováno v:
Acta Obstetricia et Gynecologica Scandinavica. 82:167-172
To evaluate the efficacy of three different doses of Nestorone progestin administered by implants for relief of pain, as well as bleeding patterns and symptoms in women with endometriosis.An open clinical study without a control group.Twenty-one wome